Cargando…

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda

Background: There are limited data on primary human immunodeficiency virus drug resistance (HIVDR) in pediatric populations. This study aimed to assess the prevalence of primary HIVDR and associated risk factors among children initiating first-line antiretroviral therapy (ART) in Uganda. Methods: At...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kityo, Cissy, Sigaloff, Kim Catherina Eve, Boender, Tamara Sonia, Kaudha, Elizabeth, Kayiwa, Joshua, Musiime, Victor, Mukuye, Andrew, Kiconco, Mary, Nankya, Immaculate, Nakatudde-Katumba, Llilian, Calis, Job C.J., Rinke de Wit, Tobias F., Mugyenyi, Peter N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2016
Materias:	Clinical Trials/Clinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931746/ https://www.ncbi.nlm.nih.gov/pubmed/26723018 http://dx.doi.org/10.1089/aid.2015.0215

Ejemplares similares

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study
por: Boender, T. Sonia, et al.
Publicado: (2012)

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
por: Kityo, Cissy, et al.
Publicado: (2017)

Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique
por: Lamorde, Mohammed, et al.
Publicado: (2014)

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure
por: Boerma, Ragna S., et al.
Publicado: (2017)

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa
por: Kityo, Cissy, et al.
Publicado: (2017)

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
por: Paton, Nicholas I, et al.
Publicado: (2017)

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda
por: Poon, Art F. Y., et al.
Publicado: (2019)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2016)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2017)

Replicability of sight word training and phonics training in poor readers: a randomised controlled trial
por: McArthur, G, et al.
Publicado: (2015)

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda
por: Bajunirwe, Francis, et al.
Publicado: (2016)

High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children
por: Boerma, Ragna S, et al.
Publicado: (2016)

Sequencing paediatric antiretroviral therapy in the context of a public health approach
por: Boerma, Ragna S, et al.
Publicado: (2015)

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study
por: Bajunirwe, Francis, et al.
Publicado: (2019)

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
por: Harbeck, Nadia, et al.
Publicado: (2016)

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
por: Oswald, Ailsa J., et al.
Publicado: (2023)

Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients
por: Binkhorst, Lisette, et al.
Publicado: (2015)

Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND)
por: Kwakkenbos, Linda, et al.
Publicado: (2022)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
por: Inzaule, Seth C., et al.
Publicado: (2018)

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries
por: Gibson, Richard M., et al.
Publicado: (2017)

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
por: Heeney, Matthew M., et al.
Publicado: (2022)

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts
por: Bajunirwe, Francis, et al.
Publicado: (2018)

Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia
por: Vissers, Maud N., et al.
Publicado: (2008)

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana
por: Vriesendorp, Reinout, et al.
Publicado: (2007)

A Randomized Controlled Trial of Glucose versus Amylase Resistant Starch Hypo-Osmolar Oral Rehydration Solution for Adult Acute Dehydrating Diarrhea
por: Ramakrishna, Balakrishnan S., et al.
Publicado: (2008)

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
por: Sawada, Hideyuki, et al.
Publicado: (2010)

Macitentan: entry-into-humans study with a new endothelin receptor antagonist
por: Sidharta, Patricia N., et al.
Publicado: (2011)

Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial
por: Koblin, Beryl A., et al.
Publicado: (2011)

Type 2 Diabetes Is Associated with Altered NF-κB DNA Binding Activity, JNK Phosphorylation, and AMPK Phosphorylation in Skeletal Muscle after LPS
por: Andreasen, Anne Sofie, et al.
Publicado: (2011)

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
por: Barrios, Carlos H., et al.
Publicado: (2010)

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy
por: Schlich-Bakker, Kathryn J., et al.
Publicado: (2007)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Esserman, Laura J., et al.
Publicado: (2011)

Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers
por: Zadoyan, G., et al.
Publicado: (2011)

Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
por: Hoever, P, et al.
Publicado: (2012)

TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials
por: Boyce, M., et al.
Publicado: (2012)

Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine
por: Haskelberg, Hila, et al.
Publicado: (2012)

The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine
por: Azuma, Junichi, et al.
Publicado: (2011)

Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
por: Mendzelevski, Boaz, et al.
Publicado: (2012)

An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects
por: Round, Patrick, et al.
Publicado: (2011)

Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)
por: Scheiman, James M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ib5n24so59oc8k5h8t755gkvkq